Abstract:Drug targets are biological macromolecules that bind drug molecules in vivo. Therefore, the system-wide identification of drug targets plays a vital role in fully understanding the mechanism of drug action, efficacy, and side effects. The unbiased screening of drug targets may accelerate the process of drug discovery and candidate screening. Mass spectrometry is a key tool for large-scale protein identification and accurate quantification owing to its high acquisition speed, resolution, and sensitivity. Mass spectrometry-based proteomics has been widely used for drug-target screening. It can systematically identify the protein-target landscape of a drug and elucidate drug-protein interactions. Commonly used drug-target characterization methods, such as labeling-based affinity enrichment, require the chemical derivatization of drug molecules, which is not only time-consuming but may also affect the affinity of the drug towards its targets. Furthermore, the spatial effects of the derivatization groups may block interactions between the drug and its targets. Considering the disadvantages of affinity-enrichment methods, strategies that do not require chemical derivatization have received widespread attention. Proteins may undergo denaturation, unfolding, and precipitation under different conditions such as high temperatures, extreme pH, denaturants, and mechanical stress. Binding to small-molecule drugs may alter the folding balance of target proteins. The conformational stability of target proteins can be stabilized by binding with drugs, and protein-drug complexes are more resistant than free proteins to the precipitation induced by different conditions. Based on this mechanism, various large-scale drug-target identification methods using protein precipitation have been developed by combining proteomics and mass spectrometry analysis, including thermal proteome profiling and solvent-, mechanical stress-, and pH-induced protein precipitation. These methods have been successfully applied to the characterization of small-molecule drug targets. In this review, we describe the protein precipitation-based methods used for the high-throughput discovery of drug targets and elucidation of the interactions between drugs and proteins in the past decade. We also summarize the characteristics of each method and discuss their application potential in drug-efficacy evaluation and drug discovery.

Virus-like Iron-Gold Heterogeneous Nanoparticles for Drug Target Screening

Drug Target Discovery by Magnetic Nanoparticles Coupled Mass Spectrometry.

Utilizing solid-state nanopore sensing for high-efficiency and precise targeted localization in antiviral drug development

Proteome interrogation using nanoprobes to identify targets of a cancer-killing molecule.

Computational Studies on the Interactions of Nanomaterials with Proteins and Their Impacts

The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells.

Novel Strategy for Screening Target Proteins by the Common Drugs─Sofosbuvir-Specific Profiling of HCV Patient Serum

A virus–target host proteins recognition method based on integrated complexes data and seed extension

Protein-based fluorescent metal nanoclusters for small molecular drug screening.

Application Of Chemistry-Based Functional Proteomics To Screening For Novel Drug Targets

Solvent-induced protein precipitation for drug target discovery on proteomic scale.

Virus-like Plasmonic Nanoprobes for Quick Analysis of Antiviral Efficacy and Mutation-Induced Drug Resistance

[Recent advances in protein precipitation-based methods for drug-target screening]

Applications of Nanotechnology in Virus Detection, Tracking, and Infection Mechanisms

High-Throughput Screening Based on Label-Free Detection of Smallmolecule Microarrays

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs.

Integrated Computational and Experimental Framework for Inverse Screening of Candidate Antibacterial Nanomedicine

Unique Roles of Gold Nanoparticles in Drug Delivery, Targeting and Imaging Applications

High throughput proteome screening for novel drug targets

Gold nanostructures for bioimaging, drug delivery and therapeutics